reverse: Open to Laparoscopic Reverse Conversion of Perforated Appendicitis

Sponsor
Zagazig University (Other)
Overall Status
Completed
CT.gov ID
NCT05283733
Collaborator
(none)
426
1
2
47.2
9

Study Details

Study Description

Brief Summary

A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in management of Acute Perforated Appendicitis

Condition or Disease Intervention/Treatment Phase
  • Procedure: reverse conversion technique
N/A

Detailed Description

Introduction: Acute appendicitis (AA), a frequent intra-abdominal surgical pathology, necessitates a thorough awareness of its symptoms, examination, diagnosis, and total surgical management. The surgical approach to AA is appendectomy; nevertheless, the medical literature continues to argue the merits of open vs laparoscopic surgery. As with other laparoscopic surgical techniques, the literature reports lower discomfort, earlier resumption of oral feeding and shorter hospital stay following laparoscopic appendectomy (LA) as compared to open appendectomy (OA). Additionally, laparoscopy has some drawbacks such as greater cost and lengthier operating durations as compared to open surgery. The goal of this clinical study: was to compare open appendectomy versus laparoscopic conversion from open (reverse conversion) for the treatment of acute perforated appendicitis in our setting. Patients and procedures: 426 patients had perforated appendectomy and divided between two groups: group A (interventional) 213 patients who were subjected to the reverse conversion technique and group B (control)213 patients who were operated by the open technique. The key end goals for comparing both groups were the rates of intraabdominal abscess, rates of wound infection, rates of ileus and rates of reoperation. The hospital length of stay and the operative time were used as secondary end goals for comparison.

Study Design

Study Type:
Interventional
Actual Enrollment :
426 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in Management of Acute Perforated Appendicitis
Actual Study Start Date :
Jan 18, 2018
Actual Primary Completion Date :
Dec 15, 2021
Actual Study Completion Date :
Dec 25, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: group A

the group who was subjected to the reverse conversion technique

Procedure: reverse conversion technique
converting open appendectomy to laparoscopic technique for proper control of intraabdominal sepsis
Other Names:
  • laparoscopic lavage
  • No Intervention: group B

    the control group who was completed by open technique

    Outcome Measures

    Primary Outcome Measures

    1. the rates of intraabdominal abscess [3 months post operative]

      rates of complications

    2. rates of wound infection [3 months post operative]

      rates of complications

    3. rates of ileus [Baseline (Hospital admission)]

    4. rates of reoperation [3 months post operative]

    Secondary Outcome Measures

    1. The hospital length of stay [up to 3 months]

      the length of hospital stay

    2. the operative time [Intraoperative]

      Time of performing the procedures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • symptoms consistent with acute perforated appendicitis,

    • had ultrasound or computed tomography (CT) evidence of acute perforated appendicitis,

    • ages ranging from 16 to 65 years.

    Exclusion Criteria:
    • radiological evidence of appendicular mass,

    • septic shock or multi-organ failure (MOF) at presentation,

    • Diabetes Mellitus (DM), renal failure, morbid obesity

    • recent (6-month) history of thromboembolic disease

    • immunomodulators,

    • a history of inflammatory bowel disease (IBD),

    • postoperative pathological report of the removed appendix revealed carcinoid or Crohn's disease,

    • American Society of Anesthesiology (ASA) classification more than II.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zagazig University Zagazig Egypt

    Sponsors and Collaborators

    • Zagazig University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed lotfy, Associate professor, Zagazig University
    ClinicalTrials.gov Identifier:
    NCT05283733
    Other Study ID Numbers:
    • ZUH 235
    First Posted:
    Mar 17, 2022
    Last Update Posted:
    Mar 17, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohamed lotfy, Associate professor, Zagazig University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 17, 2022